Delivery Method: UPS and Electronic Mail Reference #: RW2101483 Product: Tobacco
Issuing Office: Center for Tobacco Products

United States

Dear Ghazi Mustafa:

The United States Food and Drug Administration’s (FDA) Center for Tobacco Products has completed an evaluation of your corrective actions included in your Warning Letter response emailed and dated February 25, 2021, in response to our Warning Letter dated February 12, 2021. Based on our evaluation, it appears that you have taken steps to address the violations contained in the Warning Letter regarding your website https://takeoffeliquid.com.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to ensure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. This letter also will not preclude any regulatory action should violations be observed in the future.

Sincerely,
/S/
Mallory Johnson
Branch Chief
Division of Promotion, Advertising, and Labeling
Office of Compliance and Enforcement
Center for Tobacco Products

VIA UPS and Electronic Mail

cc:

Thompson Hine LLP
Attn: Eric Heyer
1919 M Street, N.W., Suite 700
Washington, D.C. 20036-1600
[email protected]

Take Off Corp
11780 Harbour Light Dr.
North Royalton, OH 44133

Prime Vape & Smoke Shop
[email protected]

Contact Privacy Inc.
[email protected]

Shopify, Inc.
[email protected]